Aptose Biosciences Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Product Pipeline
    • Overview
    • Tuspetinib for AML
    • Luxeptinib for B-cell Tumors
    • Luxeptinib for Myeloid Tumors
    • Posters & Presentations
  • Clinical Trials
    • Overview
    • Luxeptinib for CLL & NHL
    • Luxeptinib for AML
    • Tuspetinib for AML
    • Expanded Access
  • News
    • Press Releases
    • Presentations
    • Events
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • SEDAR
    • Governance
  • Join Us
    • Values & Culture
    • Perks & Benefits
    • Explore Careers
  • Contact

Press Releases

News

News

  • Press Releases
  • Presentations
  • Events

Aptose Announces Adjournment of its Special Meeting of Shareholders

Aug 15, 2024 4:30pm EDT

Aptose Reports Results for the Second Quarter 2024

Aug 08, 2024 5:06pm EDT

Aptose Announces Receipt of Deficiency Notice from Nasdaq

Jul 19, 2024 5:00pm EDT

Aptose Announces Results from Annual and Special Meeting of Shareholders

Jun 18, 2024 5:30pm EDT

Aptose Presents Tuspetinib (TUS) Clinical and Preclinical Findings at European Hematology Association (EHA) 2024 Hybrid Congress

Jun 14, 2024 7:30am EDT

Aptose Announces Closing of $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Jun 03, 2024 4:30pm EDT

Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-MarketĀ Under Nasdaq Rules

May 31, 2024 8:00am EDT

Aptose Reports Results for the First Quarter 2024

May 14, 2024 4:01pm EDT

Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024

May 06, 2024 4:30pm EDT

Aptose Reports Results for the Fourth Quarter and Full Year 2023

Mar 26, 2024 4:01pm EDT
RSS
  • Prev
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...33
    Next
    © 2025 Aptose Biosciences Inc. All Rights Reserved.
    Privacy Policy Clinical Trials Policy Disclaimer Sitemap Manage Cookie Preferences